-+ 0.00%
-+ 0.00%
-+ 0.00%

LB Pharmaceuticals presents Phase 2 NOVA-1 post hoc analysis; LB-102 cognitive benefit shows statistically significant direct effect

Reuters·03/27/2026 16:01:23

Please log in to view news